{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:49:22Z","timestamp":1792406962419,"version":"4.4.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2026,10,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Renal cell carcinoma (RCC) is the most common renal malignancy in adults. Owing to its\nhigh incidence, asymptomatic presentation, late diagnosis, and resistance to conventional therapies,\nit is associated with significant morbidity and mortality. However, current clinical trials focus more\non identifying suitable molecular biomarkers and evaluating new treatments, such as targeted agents\nand immunotherapy. This review highlights novel biomarkers and recent clinical trials for the therapeutic\nmanagement of patients with RCC. A comprehensive literature review was conducted\nusing databases such as Web of Science, MEDLINE, Scopus, PubMed, and ClinicalTrials.gov\n(https:\/\/clinicaltrials.gov\/) on novel biomarkers and various clinical trials for RCC. Recent clinical\ntrials have shown a significant increase in biomarker discovery, including DNA methylation, microRNAs,\nlong non-coding RNAs, and protein-based markers, which influence diagnosis, prognosis,\nand treatment. The treatment of RCC has progressed from cytokine-based immunotherapy to targeted\ntherapies, such as mTOR and VEGF inhibitors, immune checkpoint inhibitors, and combination\nregimens, which have greatly improved patient outcomes. Emerging approaches, including novel\nimmunological targets, adoptive cell therapies, vaccines, and oncolytic virotherapy, hold promise for\novercoming resistance and boosting efficacy, and are currently being investigated in clinical trials.\nDespite these developments, intratumoral heterogeneity, lack of prognostic biomarkers, disparities in\nclinical trials, and treatment resistance are major limitations. Ongoing research and clinical trials\nfocused on biomarker-driven precision medicine and combination approaches are expected to improve\nRCC management significantly. Validation through large multicenter trials will be necessary\nto enable the use of biomarkers for precision medicine in routine practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115748871512585261007153038","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:28:47Z","timestamp":1792405727000},"source":"Crossref","is-referenced-by-count":0,"title":["Advances in Biomarkers and Novel Therapeutics in Renal Cell Carcinoma:\nEvidence from Recent Clinical Trials"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3362-6132","authenticated-orcid":true,"given":"Bida Joshua","family":"John","sequence":"first","affiliation":[{"name":"Department of Clinical Research, Sharda School of Allied Health Sciences, Sharda University, Greater Noida, UttarPradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoma","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Sharda School of Medical Sciences &amp; Research (Formerly School ofMedical Sciences and Research), Sharda University, Greater Noida, Uttar Pradesh, 201306, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department ofPathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, 226014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Adya","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, Sharda School of Allied Health Sciences, Sharda University, Greater Noida,201310, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratnakar","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Sharda School of Allied Health Sciences, Sharda University, Greater Noida, UttarPradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871512585261007153038","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259525\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871512585261007153038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:29:01Z","timestamp":1792405741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259525\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115748871512585261007153038","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,14]]}}}